March 16, 2024Radiology Case ReportsOpen Access

Methotrexate toxicity complicating a case of rheumatoid arthritis associated Interstitial Lung Disease: Lessons to learn

View Full Paper

Ask AI

Bookmark

Fatal pulmonary toxicity developed following methotrexate therapy, severely complicating rheumatoid arthritis associated interstitial lung disease.
Between 60% and 80% of rheumatoid arthritis cases manifest pulmonary involvement, heightening vulnerability to fatal drug related pulmonary toxicity.
Highlights the lethal hazard of methotrexate administration in autoimmune arthritis with chronic dyspnea, calling for vigilant pulmonary evaluation.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Case report reveals fatal pulmonary toxicity following methotrexate therapy in rheumatoid arthritis associated interstitial lung disease, highlighting severe risks of treatment.

Cite This Study

Ikrou et al. (2024) studied this question.

synapsesocial.com/papers/68e73b9db6db6435876b5479 https://doi.org/10.1016/j.radcr.2024.02.036

View Full Paper

Ask AI

Bookmark

Implication

Case report reveals fatal pulmonary toxicity following methotrexate therapy in rheumatoid arthritis associated interstitial lung disease, highlighting severe risks of treatment.

Methotrexate toxicity complicating a case of rheumatoid arthritis associated Interstitial Lung Disease: Lessons to learn

Key Points

Discussion

Implication

Cite This Study

Methotrexate toxicity complicating a case of rheumatoid arthritis associated Interstitial Lung Disease: Lessons to learn

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider